When providers and insurers collaborate on providing efficient care in settings like accountable care organizations (ACOs) and patient-centered medical homes, it presents them with an ability to share savings. However, when a patient's care exceeds projected cost expectations, current models of shared-saving contracts can disproportionately affect insurers.
FOR IMMEDIATE RELEASE
August 7, 2013
AJMC: Option Pricing May Lead to More Cost-Effective, Collaborative Care
PLAINSBORO, NJ - When providers and insurers collaborate on providing efficient care in settings like accountable care organizations (ACOs) and patient-centered medical homes, it presents them with an ability to share savings. However, when a patient’s care exceeds projected cost expectations, current models of shared-saving contracts can disproportionately affect insurers. Findings published this month in The American Journal of Managed Care suggest that a more cost-effective solution may be possible through option pricing. This “call options” tool may resolve many payers’ concerns about entering shared saving contracts with providers.
Costs of care for a given patient are often unpredictable, varying annually depending on any amount of given factors. This random variation can make predicting a patient’s expected costs difficult, and can drastically influence the savings or losses experienced in a shared saving environment. AJMC study authors, Mark W. Friedberg, MD, MPP, Anthony M. Buendia, BA, Katharine E. Lauderdale, BA, and Peter S. Hussey, PhD, found that this volatility affects payers most as they often risk significant financial losses.
“A substantial proportion of shared savings bonuses may be paid due to chance alone (‘paying for volatility’), even if providers do nothing to contain costs,” the authors wrote. “While random variation also can produce cost overruns, the resulting penalties will not counterbalance random rewards when shared savings contracts are asymmetric.”
Insurers remain hesitant to enter shared saving contracts unless they are positive there will be efficient cost-containment efforts made by the provider. Widespread adoption of shared savings contracts will only be made possible in addressing their concerns. In implementation of option pricing, providers and payers can bridge the gap that lies between providers, who want protection against downside risk, and payers, who seek a more favorable business proposition. When payers sell “call options” as a condition of a shared savings contract, the “options can be priced to counterbalance exactly payers’ expected losses due to random variation in healthcare costs, under any shared savings arrangement, with providers large and small.” Having options will lead to a more customized shared savings contract agreement between a provider and insurer.
Option pricing is calculated based on the cost data of a network’s own patients, their own techniques of estimating benchmark costs, and their particular estimates of projected savings. After calculating option prices, payers can present a provider with a selection of potential shared saving contracts, including the option that a fee be tied to other terms like minimum savings rates, bonus caps, and risk factors.
“With healthcare costs threatening to devour other parts of the national economy, efforts to contain these costs are increasingly important,” wrote the authors. “An urgent response may require all hands on deck, including government and private payers as well as providers of all sizes.”
Shared savings contracts show promise to offer more flexible, innovative ways of encouraging cost savings in healthcare, but they must be more broadly adapted.
CONTACT: Nicole Beagin
609-716-7777 x131
nbeagin@ajmc.com
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More